{"id":692395,"date":"2022-10-05T09:01:07","date_gmt":"2022-10-05T13:01:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/"},"modified":"2022-10-05T09:01:07","modified_gmt":"2022-10-05T13:01:07","slug":"mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/","title":{"rendered":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, Oct. 5, 2022<\/span><\/span> \/PRNewswire\/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of MindMed’s management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference, taking place at the Ritz Carlton, San Francisco, CA<\/span> from October 6-7, 2022<\/span>.<\/p>\n

\n

\n
\n \"MindMed
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Cantor Fitzgerald Neurology & Psychiatry Conference
<\/b>Format: Panel presentation and one-on-one investor meetings
Panel Title: “Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment”
Panel Date: Thursday, October 6, 2022<\/span>
Panel Time: 12:10 p.m. PDT<\/span>
Location: Ritz Carlton, San Francisco, CA<\/span><\/p>\n

\n About MindMed<\/b>\n <\/div>\n

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine, and acetylcholine systems.<\/p>\n

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange<\/span> under the symbol MMED.<\/p>\n

\n For Media:<\/b>
\n media@mindmed.co<\/a>\n <\/p>\n

\n For Investors:<\/b>
\n ir@mindmed.co<\/a>\n <\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology–psychiatry-conference-301641526.html<\/a><\/p>\n

SOURCE Mind Medicine (MindMed) Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK , Oct. 5, 2022 \/PRNewswire\/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of MindMed’s management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference, taking place at the Ritz Carlton, San Francisco, CA from October 6-7, 2022. Cantor Fitzgerald Neurology & Psychiatry Conference Format: Panel presentation and one-on-one investor meetingsPanel Title: “Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment”Panel Date: Thursday, October 6, 2022Panel Time: 12:10 p.m. PDTLocation: Ritz Carlton, San Francisco, CA About MindMed MindMed is a clinical stage biopharmaceutical company developing … <\/p>\n

Continue reading “MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Oct. 5, 2022 \/PRNewswire\/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of MindMed’s management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference, taking place at the Ritz Carlton, San Francisco, CA from October 6-7, 2022. Cantor Fitzgerald Neurology & Psychiatry Conference Format: Panel presentation and one-on-one investor meetingsPanel Title: “Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment”Panel Date: Thursday, October 6, 2022Panel Time: 12:10 p.m. PDTLocation: Ritz Carlton, San Francisco, CA About MindMed MindMed is a clinical stage biopharmaceutical company developing … Continue reading "MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-05T13:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference\",\"datePublished\":\"2022-10-05T13:01:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/\"},\"wordCount\":226,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1830067\\\/MindMed_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/\",\"name\":\"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1830067\\\/MindMed_Logo.jpg\",\"datePublished\":\"2022-10-05T13:01:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1830067\\\/MindMed_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1830067\\\/MindMed_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/","og_locale":"en_US","og_type":"article","og_title":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk","og_description":"PR Newswire NEW YORK , Oct. 5, 2022 \/PRNewswire\/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of MindMed’s management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference, taking place at the Ritz Carlton, San Francisco, CA from October 6-7, 2022. Cantor Fitzgerald Neurology & Psychiatry Conference Format: Panel presentation and one-on-one investor meetingsPanel Title: “Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment”Panel Date: Thursday, October 6, 2022Panel Time: 12:10 p.m. PDTLocation: Ritz Carlton, San Francisco, CA About MindMed MindMed is a clinical stage biopharmaceutical company developing … Continue reading \"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-05T13:01:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference","datePublished":"2022-10-05T13:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/"},"wordCount":226,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/","name":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg","datePublished":"2022-10-05T13:01:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1830067\/MindMed_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}